US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
We have updated Antiviral Drugs Market with respect to COVID-19 Business Impact. Inquire before buying This report focuses on the Antiviral Drugs market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Antiviral Drugs market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.
Global Antiviral Drugs Market: Segment AnalysisThe research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.
Global Antiviral Drugs Market: Regional AnalysisThe research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.
Global Antiviral Drugs Market: Competitive LandscapeThis section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies ProfiledGilead Sciences and GlaxoSmithKline to Lead the Market In terms of revenue, Gilead Sciences dominated the antiviral agents market owing to the remarkable sale of its drugs such as Biktarvy, Harvoni, etc. Genvoya, a leading fixed dose combination antiretroviral drug by Gilead, accounted for a revenue of more than USD 4.5 billion in 2018, which propelled the market share of the company. Another leading combination called Triumeq by GSK, generated over USD 3.4 billion revenue in 2018, which has provided a strategic position to the company in global market. Another key player operating in the market is Abvie. The company is growing because of its significant performance in Hepatitis C.
List of key Companies Covered:
Table of Content Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data Sources Chapter 2. Executive Summary Chapter 3. Antiviral Drugs Market 3.1. Market Segmentation 3.2. Market Size and Growth Prospects, 2019 - 2029 3.3. Value Chain Analysis 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.2. Market restraint analysis Chapter 4. Market Size by Application 4.1 Antiviral Drugs Market Consumption by Application (2015-2020) 4.2 Antiviral Drugs Market Consumption by Application (2020-2029) | read more...